Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Infection surveillance systems generate data that help public and private health officials understand emerging and existing infectious and non-infectious diseases. Infection surveillance solutions help prevent or stop the spread of infections in healthcare settings. These solutions use algorithms with specialized data mining software, electronic medical records, and completely automated HAI surveillance by employing clinical support based knowledge that aids in the identification of certain clinical terms.
The North American infection surveillance solutions market is presently being driven by several driving factors. Both the United States and Canada are dominating the market in the NA region. Constant focus on preventing and identifying emerging healthcare-associated infections and infections associated with medical instruments used in hospitals and clinics is supporting the growth of the infection surveillance solutions market across the region. Presence of several government regulations, policies and surveillance systems for preventing healthcare associated infections is further propelling the market growth. For instance, Canadian Nosocomial Infection Surveillance Program (CNISP) is the Canada’s national HAI surveillance system. It collects data on various antimicrobial resistant organisms (ARO), HAI, and hospital-level antimicrobial utilization.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the infection surveillance solutions market. In addition, complete analysis of changes on infection surveillance solutions market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Increasing number of hospitals and clinical laboratories for the diagnosis and the detection of the COVID-19 patient is improving the growth of infection surveillance solutions market. High-throughput technologies are being leveraged by a growing number of hospitals to prevent and control healthcare associated as well as COVID-19 infection spread effectively and rapidly on a wide scale.
The study analyses North America infection surveillance solutions market based on product, end user and country.
Based on product, the North America infection surveillance solutions market segmented into software and services segment. The software segment dominated the market in 2021 and is likely to witness rapid growth during the forecast period. The software segment is further sub-segmented into on-premise and web-based. And major services such as product support & maintenance services, training & consulting services and implementation services are analyzed in the market. Services segment hold the second largest market share. An increasing adoption of several services in various hospitals, long-term care facilities, ambulatory care centers and academic institutes for the management of records and maintaining the standard of patient infectious rate is accredited to the growth of the segment.
Major end users of North America infection surveillance solutions market are hospitals, long-term care facilities, others. Hospitals is expected to gain major market share during the forecast period (2019-2028). The hospitals segment include sub-segments such as large hospitals, medium-sized hospitals and small hospitals. However, long-term care facilities segment is anticipated to account for second largest share in the market during the projected timeframe, owing to factors such as growing number surgeries performed in long-term care facilities and rising geriatric population across the globe.
Country wise, the study is comprised of the key countries such as the US, Mexico and Canada. The US held the largest market share of North America infection surveillance solutions market and is likely to dominate the market over the estimated time frame. Well-established healthcare industry of the country and growing technological advancements in healthcare sector, increased awareness regarding HAIs, presence of several infection surveillance systems, and high disposable income of the consumers on the health are the major factors that are likely to enhance the growth of infection surveillance solutions market in NA region.
The major key players of market includes Becton Dickson & Company (United States), Baxter International Inc (United States), Premier Inc (United States), Wolters Kluwer N.V (Netherlands), Gojo Industries, Inc (United States), RL Solutions (United States), Truven Health Analytics (An IBM Company) (United States), DEB Group Ltd (United Kingdom), Hygreen, Inc (United States), Vigilanz Corporation (United States), Cerner Corporation (United States), Epic Systems Corporation (United States), Vecna Technologies (United States), Emerald Health Information System (Canada), Medexter Healthcare (Austria), and PeraHealth Inc (United States) among others.
June 2021: RLDatix announced the acquisition of UK-based Allocate Software, which is a provider of human capital management solutions and helps healthcare organizations to deliver safe and effective care.
October 2020: RLDatix, the global provider of intelligent patient safety solutions, acquired Verge Health, the recognized best-in-class credentialing software provider. This acquisition joins two companies in the governance, risk, and compliance healthcare software market and dramatically accelerated an essential shift from a reactive approach to risk management to one rooted in safety and prevention.
May 2020: VigiLanz, a clinical surveillance company announced the launch of COVID Quick Start – a new solution which will enable hospitals to prepare for, prevent, and respond to the spread of COVID-19 and other respiratory viral illnesses.
September 2018: Wolters Kluwer N.V launched the clinical surveillance solution Sentri7. This solution gives hospital tools and resources to stay in front of new challenges and battle the anti-biotic resistant bacteria.
The study analyses North America infection surveillance solutions market based on product, end user, and country. Based on product, the North America infection surveillance solutions market segmented into software and services segment. The software segment is likely to dominate the market over the forecast period. Increased adoption of infection surveillance software solutions in end use industries owing to its several benefits is attributed to the market growth. Major end users of North America infection surveillance solutions market are hospitals, long-term care facilities, others. The hospitals segment is likely to register fastest growth in years to come owing to the increasing number of hospital admissions every year. Country wise, the study is comprised of the key countries such as the US, Mexico and Canada.
Why to buy this report:
